Conmed (CNMD) Depreciation & Amortization (CF) (2010 - 2026)

Conmed has reported Depreciation & Amortization (CF) for 17 years, with the latest figure at $4.2 million in Q1 2026.

• For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 1.44% year-over-year to $4.2 million; the trailing twelve-month figure through Mar 2026 stood at $17.1 million (up 1.71% YoY), and the FY2025 full-year result was $17.1 million, up 3.24% from the prior year.
• Depreciation & Amortization (CF) for Q1 2026 stood at $4.2 million, up from $4.1 million in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $4.5 million in Q2 2025, with the low at $3.9 million in Q3 2023.
• Historically, Depreciation & Amortization (CF) has averaged $4.1 million across 5 years, with a median of $4.1 million in 2025.
• Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) retreated 15.24% — and 2025, when it advanced 7.23%.
• Conmed's Depreciation & Amortization (CF) stood at $4.0 million in 2022, then gained by 0.62% to $4.1 million in 2023, then climbed by 3.63% to $4.2 million in 2024, then fell by 3.17% to $4.1 million in 2025, then rose by 2.66% to $4.2 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $4.2 million (Q1 2026), $4.1 million (Q4 2025), and $4.4 million (Q3 2025), per Business Quant data.